Tablo Sales Boost Outset Bottom Line
Product revenues increased 5.5% and service revenues increased in Q3 of 2022 over 2021. The Tablo is used for acute and home HD, and Outset won a 5-year VA contract for Tablo in hospitals and homes.
Read the full article » | Posted 12-19-2022
Related Articles
- Baxter ASN Presence, 2018 Posted 10-05-2026
- Fresenius Kidney Care Reports PD Breakthroughs Posted 10-05-2026
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026

